Skip to main content

Table 5 Differences of characteristics of BSI burn patients receiving appropriate and inappropriate empirical antimicrobial therapy

From: Epidemiology and outcomes of bloodstream infections in severe burn patients: a six-year retrospective study

Variable

Empirical antimicrobial therapy

Appropriate

n = 79

Inappropriate

n = 57

p-value

Male

59 (74.7)

41 (71.9)

0.719

Age (years) (median, IQR)

47 [34,54]

46 [38,56]

0.601

Comorbidities

19 (24.1)

15 (26.3)

0.763

Type of burn

 Flame

70 (88.6)

46 (80.7)

0.199

 Chemical

2 (2.5)

3 (5.3)

0.404

 Hyperthermia liquid

5 (6.3)

7 (12.3)

0.227

 Other

2 (2.5)

1 (1.8)

0.761

%TBSA

 20–39

16 (20.3)

11 (19.3)

0.341

 40–59

19 (24.1)

13 (22.8)

 60–79

23 (29.1)

10 (17.5)

 ≥ 80

21 (26.6)

23 (40.4)

 Accompanying third degree burns

73 (92.4)

53 (93.0)

0.899

 Inhalation injury

51 (64.6)

29 (50.9)

0.110

 Mechanical ventilation

48 (60.8)

34 (59.6)

0.896

Coinfections before bacteremia

 Skin infection

65 (82.3)

37 (64.9)

0.021

 Pneumonia

38 (48.1)

19 (33.3)

0.085

 CVC infection

24 (30.4)

14 (24.6)

0.456

 UTI

3 (3.8)

3 (5.3)

0.681

 AKI

9 (11.4)

13 (22.8)

0.074

 Septic shock

9 (11.4)

9 (15.8)

0.455

 MODS

7 (8.9)

12 (21.1)

0.043

 Hospital length of stay, days (median, IQR)

51 [34,68]

47 [30,66]

0.642

 Inappropriate definitive antimicrobial therapy

3 (3.8)

13 (22.8)

0.001

 Outcomes

 30-day mortality

6 (7.6)

10 (17.5)

0.076

 60-day mortality

11 (13.9)

14 (24.6)

0.114

  1. BSI bloodstream infection, IQR interquartile range, TBSA total body surface area, CVC central venous catheter, UTI urinary tract infection, AKI acute kidney injury, MODS multiple organ dysfunction syndrome